The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Recommendation of “Hold” by Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been given a consensus rating of “Hold” by the sixteen ratings firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a sell rating, five have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $81.8462.

COO has been the topic of several recent research reports. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Wells Fargo & Company reissued a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Stifel Nicolaus decreased their target price on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Finally, KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $70.70 on Monday. Cooper Companies has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The business’s fifty day moving average price is $65.26 and its two-hundred day moving average price is $72.92. The firm has a market capitalization of $13.79 billion, a PE ratio of 59.92, a P/E/G ratio of 1.85 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company posted $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts expect that Cooper Companies will post 4.63 EPS for the current year.

Institutional Trading of Cooper Companies

Several large investors have recently added to or reduced their stakes in COO. New York Life Investment Management LLC boosted its position in Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares during the period. Root Financial Partners LLC grew its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. Essential Partners LLC increased its holdings in shares of Cooper Companies by 23.4% during the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after purchasing an additional 166 shares during the period. Allworth Financial LP increased its holdings in shares of Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 167 shares during the period. Finally, Blue Trust Inc. increased its holdings in shares of Cooper Companies by 13.9% during the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after purchasing an additional 185 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.